Ropinirole - redOrbit

Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)

2012-05-18 02:24:48

MORRISTOWN, N.J., May 18, 2012 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it received US FDA approval of Ropinirole Extended-Release

For Parkinson's Disease Treatment, Surveyed Neurologists in France Use Once-Daily Formulations of Requip and Mirapex More Frequently Than Prescribers in Germany, Italy, Spain or the United Kingdom

2010-11-30 07:00:00

BURLINGTON, Mass., Nov.

Increased Uptake of Currently-Available Therapies Will Drive Modest $400 Million Growth in the Parkinson's Disease Drug Market from 2009 to 2019

2010-09-09 07:00:00

BURLINGTON, Mass., Sept.

Titan Receives SBIR Grant to Investigate Long Term Treatment for Parkinson's Disease

2010-07-26 15:15:00

SOUTH SAN FRANCISCO, Calif., July 26 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc.

Boehringer Ingelheim's Pramipexole ER Will Garner Peak Year Sales of $250 to $500 Million for the Treatment of Parkinson's Disease

2010-01-12 07:00:00

WALTHAM, Mass., Jan.

News - Ropinirole

Breaking News

Streaming Video

Images and Photos

Space Exploration

Science and Research

Technology

My Health